Clinical Study on Treatment of Chronic Persistent Bronchial Asthma

• Status: Unknown status
• Trial end date: 2020-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Investigators aimed to evaluate the clinical efficacy of integrated traditional Chinese and Western medicine in the treatment of asthma, and to further optimize the prescription of Chinese medicine treatment.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai University of Traditional Chinese Medicine
• Collaborator: Longhua Hospital

Criteria

Inclusion Criteria:

• Patient diagnosed with chronic persistent asthma

• Patients had positive bronchodilator reversibility test or positive bronchial challenge test or more than 50 parts per billion of FENO before

• Conform to the predetermined 2 TCM Syndrome Types

• Patients who have given written informed consent

Exclusion Criteria:

• Smoking and continuous exposure to hazardous environment

• With fever, or severity of intermittent state, high degree of sustained, or with respiratory failure, etc.

• Pulmonary emphysema, chronic obstructive pulmonary disease, pulmonary emphysema, pulmonary heart disease, pneumonia, lung cancer and other lung diseases

• Patients who are allergic to therapeutic medicine